AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Company Reports - CBNB)
Kyowa Hakko Kogyo Co Ltd (Kyowa Hakko) announced consolidated financial results for 1H ended Sep 2006. Consolidated net sales for 1H 2006 were mainly affected by the ending of the distribution agreement for antimycological agent Itrizole and reductions in pharmaceutical prices and declined to Yen 173.1 bn. A strong performance from core pharmaceutical products and a decline in personnel costs and R&D expenses led to operating income of Yen 14.5 bn for 1H 2006-2007 (+18.4% over 1H 2005-2006). Consolidated net income was affected by extraordinary losses, including losses on the sale of subsidiaries' shares and …